1.99
Connect Biopharma Holdings Ltd (CNTB) 最新ニュース
CNTB Stock Price, Quote & Chart - ChartMill
Connect Biopharma touts Rademikibart's edge as SEABREEZE data looms in 2026 - MSN
CNTB Technical Analysis | Trend, Signals & Chart Patterns | CONNECT BIOPHARMA HOLDINGS L (NASDAQ:CNTB) - ChartMill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Connect Biopharma director James Huang acquires $371,610 in shares - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Connect Biopharma director James Huang acquires $371,610 in shares By Investing.com - Investing.com UK
Director-linked fund boosts Connect Biopharma (NASDAQ: CNTB) stake - Stock Titan
[EFFECT] Connect Biopharma Holdings Ltd SEC Filing - Stock Titan
Connect Biopharma (CNTB) Gains 4.6% as Shares Test Key Resistance at $2.61Earnings Beat Stocks - newsline.com
This Avalyn Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Canaccord Genuity Initiates Connect Biopharma at Buy With $6 Price Target - Moomoo
Connect Biopharma Touts Rademikibart’s Edge as SEABREEZE Data Looms in 2026 - inkl
Cantor Fitzgerald initiates Connect Biopharma stock with overweight rating - Investing.com
Cantor Fitzgerald initiates Connect Biopharma stock with overweight rating By Investing.com - Investing.com South Africa
Connect Biopharma Growth Plans Raise Financial Discipline Focus - Kalkine Media
Here's Why Connect Biopharma Holdings (NASDAQ:CNTB) Must Use Its Cash Wisely - simplywall.st
Why Is Connect Biopharma Holdings Limited (CNTB) Stock Down Today? - Meyka
Wei Zheng holds 6.2% of Connect Biopharma (CNTB) after March offering - Stock Titan
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Could Be Quite Risky - Yahoo Finance
Connect Biopharma Holdings LtdProposed Resale Of Up To 6.1 Million Ordinary Shares Of Connect BiopharmaSEC Filing - TradingView
Connect Biopharma (CNTB) files resale registration for 6.13M shares - Stock Titan
Connect Biopharma | F-3: Registration statement for specified transactions by certain foreign private issuers - Moomoo
Connect Biopharma : Corporate PresentationMay 2026 (3b1153) - marketscreener.com
BTIG Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference - The Manila Times
Connect Biopharma 4Q Loss/Shr 34c >CNTB - Moomoo
Connect Biopharma Holdings Ltd 2026 Q1 Financial Report: Earnings, Cash Flow & Company Overview - Minichart
Connect Biopharma Holdings Releases Q1 2026 Financial Results - AlphaStreet
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Connect Biopharma Holdings Ltd 1Q 2026: Revenue $169K, EPS ($0.34) — 10-Q Summary - TradingView
Connect Biopharma (NASDAQ: CNTB) boosts R&D and cash with Q1 2026 loss - Stock Titan
Connect Biopharma (NASDAQ: CNTB) widens Q1 loss as rademikibart trials advance - Stock Titan
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Sheboygan Press
BML Capital Management LLC Sells 858,613 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB - MarketBeat
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Northland Securities Weighs in on CNTB Q1 Earnings - MarketBeat
Connect Biopharma asthma, COPD trials to continue as planned By Investing.com - Investing.com India
CNTB SEC FilingsConnect Biopharma Holdings Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Connect Biopharma asthma, COPD trials to continue as planned - Investing.com
Connect Biopharma Continues Phase 2 Seabreeze STAT Trials for Rademikibart in Asthma and COPD with Topline Data Expected Mid-2026 - Minichart
Connect Biopharma: DMC clears interim analysis; Phase 2 Seabreeze STAT enrollment to continue - TradingView
Connect Biopharma (NASDAQ: CNTB) DMC backs Seabreeze STAT trials, topline data mid-2026 - Stock Titan
Interim review leaves asthma, COPD drug studies unchanged ahead of mid-2026 data - Stock Titan
Connect Bio (CNTB) Stock: Market Efficiency (At Highs) 2026-04-20Trending Picks - Cổng thông tin điện tử tỉnh Lào Cai
CNTB | Connect Biopharma Holdings Limited Insider Trading - Quiver Quantitative
Connect Biopharma Holdings (CNTB) insider-linked stake of 9.6% disclosed - Stock Titan
大文字化:
|
ボリューム (24 時間):